As I've posted on numerous occasions, Copaxone is a very much easier drug to characterize than Lovenox. If the FDA was willing to approve MNTA's generic Lovenox, MNTA's obtaining approval for generic Copaxone in due course is close to a fait accompli, IMO.
Market Data 
Markets 
AI
